The Effect of Konjac Grain in the Post-prandial Glycaemic Response of Healthy Subjects
Konjac
1 other identifier
interventional
20
1 country
1
Brief Summary
determine the effect of giving the Konjac-Grain formula as a mixture of white rice in suppressing post-prandial glucose absorption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2023
CompletedFirst Posted
Study publicly available on registry
May 9, 2023
CompletedStudy Start
First participant enrolled
May 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2023
CompletedMay 9, 2023
April 1, 2023
6 days
March 29, 2023
May 8, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Change Post prandial blood glucose
Without supplementation, followed by Supplementation with Dietary Fibre the Konjac-Grain week 1, repeated until week 6, blood collected 2 hours after meals with a 3" fine needle 10ml Citrat-Tube blood Glucose (mg/dl or mmol/L) one drop (50microliter) of blood from citrat-Tube was transferred to the Glucose test strip. Glucose was measured with disposable 'test-strip', which is then inserted into an electronic blood glucose meter (device: Accu-Check Instant S Glucose from Roche) . Normal value:70 to 99 mg/dL (3.9 to 5.5 mmol/L).
2 hours after meals.
Change Post prandial blood HbA1c
Without supplementation, followed by Supplementation with Dietary Fibre the Konjac-Grain week 1, repeated until week 6, blood collected 2 hours after meals with a 3" fine needle 10ml Citrat-Tube blood HbA1c (mg/dl) one drop (50microliter) of blood from citrat-Tube was transferred to the HbA1c test strip. HbA1c was measured with disposable 'test-strip', which is then inserted into an electronic blood glucose meter (device: Accu-Check Instant S HbA1c from Roche) . Normal value:80-180 mg/dL
2 hours after meals.
Study Arms (1)
Konjac-Grain
EXPERIMENTALWithout supplementation, followed by Supplementation with Konjac grain from PT. AMBICO
Interventions
Without supplementation, followed by Supplementation with Dietary Fibre the Konjac-Grain week 1, repeated until week 6, blood collected with a fine needle 10ml citrate-Tube Glucose was measured with disposable 'test-strip', which is then inserted into an electronic blood glucose meter (device: Accu-Check Instant S Glucose from Roche) . Normal value:70 to 99 mg/dL (3.9 to 5.5 mmol/L). Further HbA1c (glycated Hemoglobin A1c) concentration was checked with disposable 'test-strip', which is then inserted into an electronic HbA1c meter (device: Accu-Check Instant S HbA1c from Roche). Unit value fir HbA1c = mg/dl
Eligibility Criteria
You may qualify if:
- Healthy male or female, aged 18-50 years
- Not currently taking any medication
- Do not have a history of metabolic diseases such as hypertension, prediabetes, metabolic syndrome, non-alcoholic fatty liver disease (NAFLD) previously from the results of doctor and laboratory examinations.
- Agree to be included as a research subject (by signing an informed consent)
You may not qualify if:
- Was experiencing an acute infectious disease at the time of the study
- Lack of sleep or heavy physical activity during the study
- Subjects experienced pregnancy during the study
- Subjects withdrew at any time during the research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitas Katolik Widya Mandala Surabaya
Surabaya, East Java, 60112, Indonesia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Clinical Pharmacology research laboratories
Study Record Dates
First Submitted
March 29, 2023
First Posted
May 9, 2023
Study Start
May 10, 2023
Primary Completion
May 16, 2023
Study Completion
May 31, 2023
Last Updated
May 9, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share
Share after publication